{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T17:51:15Z","timestamp":1791741075433,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009780","name":"Region Sk\u00e5ne","doi-asserted-by":"publisher","award":["81234"],"award-info":[{"award-number":["81234"]}],"id":[{"id":"10.13039\/501100009780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ijantimicag.2022.106567","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T02:14:06Z","timestamp":1646964846000},"page":"106567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Treatment outcome with penicillin G or cloxacillin in penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective cohort study"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3513-7579","authenticated-orcid":false,"given":"Malin","family":"Hagstrand Aldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4577-714X","authenticated-orcid":false,"given":"Robert","family":"Kavyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5566-6350","authenticated-orcid":false,"given":"Fredrik","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa I.","family":"P\u00e5hlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2022.106567_bib0001","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.spid.2004.02.001","article-title":"Penicillin: its discovery and early development","volume":"15","author":"Ligon","year":"2004","journal-title":"Semin Pediatr Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0002","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(48)92166-7","article-title":"Infection by penicillin-resistant staphylococci","volume":"2","author":"Barber","year":"1948","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0003","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1126\/science.99.2579.452","article-title":"Extraction of a highly potent penicillin inactivator from penicillin resistant staphylococci","volume":"99","author":"Kirby","year":"1944","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0004","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1080\/23744235.2017.1280617","article-title":"Penicillin-susceptible Staphylococcus aureus: susceptibility testing, resistance rates and outcome of infection","volume":"49","author":"Hagstrand Aldman","year":"2017","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0005","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.amjmed.2016.01.048","article-title":"Back to the future: penicillin-susceptible Staphylococcus aureus","volume":"129","author":"Cheng","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0006","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ijantimicag.2019.05.020","article-title":"Benzylpenicillin versus flucloxacillin for penicillin-susceptible Staphylococcus aureus bloodstream infections from a large retrospective cohort study","volume":"54","author":"Henderson","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0007","first-page":"3353","article-title":"Reappearance and treatment of penicillin-susceptible Staphylococcus aureus in a tertiary medical centre","volume":"70","author":"Chabot","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0008","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/jac\/dkt108","article-title":"Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case\u2013control and cohort analysis","volume":"68","author":"Nissen","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0009","series-title":"Benzylpenicillin. Rational for clinical breakpoints, version 1.0","year":"2010"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0010","series-title":"Breakpoint tables for interpretation of MICs and zone diameters. Version 9.0, 2019","year":"2019"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0011","series-title":"Regional riktlinje f\u00f6r Staphylococcus aureus bakteriemi hos vuxna [Regional guideline for Staphylococcus aureus bacteraemia in adults]","author":"Hagstrand-Aldman","year":"2018"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0012","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3109\/00365548.2011.641504","article-title":"Long-term outcome of invasive Staphylococcus aureus infections","volume":"44","author":"Jacobsson","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0013","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1128\/AAC.02800-14","article-title":"Comparison of cefazolin versus oxacillin for treatment of complicated bacteremia caused by methicillin-susceptible Staphylococcus aureus","volume":"58","author":"Li","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167112","article-title":"Comparable effectiveness of first week treatment with anti-staphylococcal penicillin versus cephalosporin in methicillin-sensitive Staphylococcus aureus bacteremia: a propensity-score adjusted retrospective study","volume":"11","author":"Forsblom","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0015","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/cid\/ciy766","article-title":"Good studies evaluate the disease while great studies evaluate the patient: development and application of a desirability of outcome ranking endpoint for Staphylococcus aureus bloodstream infection","volume":"68","author":"Doernberg","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0016","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/cid\/civ495","article-title":"Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)","volume":"61","author":"Evans","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0017","doi-asserted-by":"crossref","first-page":"631","DOI":"10.5811\/westjem.2018.4.38383","article-title":"Understanding the use of composite endpoints in clinical trials","volume":"19","author":"McCoy","year":"2018","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2019.100486","article-title":"Choosing primary endpoints for clinical trials of health care interventions","volume":"16","author":"McLeod","year":"2019","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0019","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cmi.2016.10.023","article-title":"Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition","volume":"23","author":"Harris","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jhin.2010.07.015","article-title":"Mortality in patients with meticillin-resistant Staphylococcus aureus bacteraemia, England 2004\u20132005","volume":"77","author":"Lamagni","year":"2011","journal-title":"J Hosp Infect"},{"issue":"Suppl 4","key":"10.1016\/j.ijantimicag.2022.106567_bib0021","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1086\/598186","article-title":"Staphylococcus aureus bloodstream infections: definitions and treatment","volume":"48","author":"Corey","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0022","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0023","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0024","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1128\/AAC.36.12.2639","article-title":"Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy","volume":"36","author":"Korvick","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0025","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1469-0691.2009.02901.x","article-title":"Severity of illness scoring systems in patients with bacteraemic pneumococcal pneumonia: implications for the intensive care unit care","volume":"15","author":"Feldman","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0026","series-title":"MIC and zone diameter distributions and ECOFFs","year":"2021"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0027","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/phar.2124","article-title":"Clinical outcomes with penicillin versus alternative \u03b2-lactams in the treatment of penicillin-susceptible Staphylococcus aureus bacteremia","volume":"38","author":"Shah","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0028","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/00365540110080908","article-title":"Antibiotics differ in their tendency to cause infusion phlebitis: a prospective observational study","volume":"34","author":"Lanbeck","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0029","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/00365540310010994","article-title":"Dicloxacillin: a higher risk than cloxacillin for infusion phlebitis","volume":"35","author":"Lanbeck","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0030","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ijantimicag.2018.04.007","article-title":"Acute kidney injury during treatment with high-dose cloxacillin: a report of 23 cases and literature review","volume":"52","author":"Lavergne","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2022.106567_bib0031","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/cid\/cis889","article-title":"Telephone consultation cannot replace bedside infectious disease consultation in the management of Staphylococcus aureus bacteremia","volume":"56","author":"Forsblom","year":"2013","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485792200067X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485792200067X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:37:47Z","timestamp":1767137867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485792200067X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S092485792200067X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2022.106567","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment outcome with penicillin G or cloxacillin in penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2022.106567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106567"}}